Default image

Diringer Lab

Michael N. Diringer, MD

All NNICU physicians have specialized research interests directed at improving the care we provide our patients. A unique aspect of this facility is that it is the only Neuro-ICU in the country with a positron emission tomography (PET) scanner located on site.

Research profile

Default image

Eisenman Lab

Lawrence N. Eisenman, MD, PhD

The Eisenman lab's primary research interest in the role of GABA receptors both in the normal physiology of the brain and in pathological states, particularly epilepsy. GABA is the major inhibitory neurotransmitter in the central nervous system, and dysfunction in the GABA system is a major component of the pathology of epilepsy.

Research profile

Default image

Fluid Biomarker Core Lab

Anne Fagan, PhD | Suzanne E. Schindler, MD, PhD

The Fluid Biomarker Core has studied Alzheimer disease from multiple angles for more than 20 years. Currently the lab focuses on fluid biomarkers of disease with a particular interest in identifying individuals with preclinical and early stage AD. Our laboratory uses enzyme-linked immunosorbent assays (ELISA), bead-based immunoassays, single-molecule counting systems and automated immunoassays to study protein biomarkers in cerebrospinal fluid and plasma.

Research profile — Anne Fagan

Research profile — Suzanne Schindler

Default image

Gallardo Lab

Gilbert Gallardo, PhD

Understand the molecular mechanisms that regulate reactive astrocytes and their neurotoxicity in neurodegenerative diseases, including Alzheimer’s disease, by utilizing a combination of biochemistry, molecular biology, cellular models of inflammation and mouse models of neurodegenerative diseases.

Research profile

Default image

Geisler Lab

Stefanie Geisler, MD

The goal of the Geisler lab is to identify new therapeutic agents that can be translated into relevant treatment strategies for patients suffering from peripheral neuropathies. We integrate genetic data from patients and analysis of patient-derived neurons with information from cell and animal models to gain insight into molecular mechanisms underlying axon degeneration and regeneration.

Research profile

Default image

Holtzman Lab

David Holtzman, MD

A major interest in the Holtzman lab is in understanding basic mechanisms underlying acute and chronic cell dysfunction in the central nervous system particularly as these mechanisms may relate to Alzheimer’s disease (AD).

Research profile

Default image

Ju Lab

Yo-El Ju, MD, MSCI

The Ju lab studies the relationship between sleep and neurodegenerative diseases through translational and clinical research.

Research profile

Default image

Kotzbauer Lab

Paul Kotzbauer, MD, PhD

The Kotzbauer lab is working to understand mechanisms of neurodegeneration underlying Parkinson’s disease and related disorders. Specific types of pathological neuronal inclusions that occur in Parkinson’s disease also occur in other neurodegenerative diseases, suggesting that common mechanisms of pathogenesis may be involved.

Research profile

Default image

Kress Lab

Geraldine Kress, PhD

My research interests focus on understanding interactions between cognitive function and the circadian system during the aging process and Alzheimer’s disease (AD) progression in order to identify pathophysiology changes, mechanisms, and possible strategies to ameliorate disease progression.

Research profile

Default image

Kummer Lab

Terrance T. Kummer, MD, PhD

Research at the Kummer lab and in our collaborative group is focused on the mechanisms of cellular damage in traumatic brain injury (TBI) and in Alzheimer’s disease, with a particular focus on synaptic and other forms of gray matter injury. TBI is a major cause of morbidity and mortality in the U.S. and worldwide and a major risk factor for the development of Alzheimer’s disease.

Research profile